Shanghai Pharmaceuticals Holding Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000012B3
HKD
11.73
0.06 (0.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
84,927.39
75,147.07
80,291.17
76,424.64
75,657.55
70,966.32
76,404.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
84,927.39
75,147.07
80,291.17
76,424.64
75,657.55
70,966.32
76,404.92
Raw Material Cost
75,795.15
66,919.58
72,652.38
68,622.58
68,375.49
63,394.59
69,270.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
392.29
444.46
429.45
478.65
474.80
508.21
510.37
Selling and Distribution Expenses
5,490.12
5,010.16
4,858.43
4,894.27
4,241.12
4,520.01
4,275.64
Other Expenses
13.61
37.01
8.91
-5.69
-1.94
27.25
-1.55
Total Expenditure (Excl Depreciation)
81,813.62
72,744.26
78,029.36
73,938.56
73,072.00
68,695.35
74,041.50
Operating Profit (PBDIT) excl Other Income
3113.8
2402.8
2261.8
2486.1000000000004
2585.6
2271
2363.4
Other Income
262.37
175.37
288.12
3,518.62
100.95
370.30
253.33
Operating Profit (PBDIT)
3,022.42
2,957.44
2,761.29
6,081.98
3,283.44
2,832.30
3,112.05
Interest
392.29
444.46
429.45
478.65
474.80
508.21
510.37
Exceptional Items
69.29
240.20
40.85
40.95
40.42
-182.57
30.38
Gross Profit (PBDT)
9,132.24
8,227.50
7,638.79
7,802.06
7,282.07
7,571.73
7,133.94
Depreciation
0.00
869.94
866.60
785.33
778.19
733.97
738.53
Profit Before Tax
2,699.42
1,883.25
1,506.10
4,858.95
2,070.87
1,407.54
1,893.53
Tax
642.18
585.91
530.96
1,417.26
547.98
571.99
431.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,599.84
633.46
752.00
3,372.68
1,425.29
538.93
1,210.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,599.84
633.46
752.00
3,372.68
1,425.29
538.93
1,210.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
487.87
449.82
331.27
246.87
328.37
376.73
341.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,087.71
1,083.28
1,083.27
3,619.55
1,753.65
915.67
1,551.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.13
1.11
1.09
1.1
1.07
1.06
1.11
Reserves
87,729.91
84,528.83
82,829.97
82,269.33
78,332.71
76,278.06
78,455.26
Earnings per share (EPS)
0.43
0.17
0.2
0.91
0.38
0.15
0.33
Diluted Earnings per share
0.43
0.17
0.2
0.91
0.38
0.15
0.33
Operating Profit Margin (Excl OI)
3.25%
2.54%
2.0%
2.33%
3.18%
2.43%
2.77%
Gross Profit Margin
3.18%
3.66%
2.96%
7.39%
3.77%
3.02%
3.44%
PAT Margin
1.88%
0.84%
0.94%
4.41%
1.88%
0.76%
1.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 13.01% vs -6.41% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 92.72% vs 0.00% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -0.79% vs 12.49% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -11.74% vs 3.49% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shanghai Pharmaceuticals Holding Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
84,927.39
617.00
84,310.39
13,664.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
84,927.39
617.00
84,310.39
13,664.57%
Raw Material Cost
75,795.15
98.34
75,696.81
76,974.59%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
392.29
12.51
379.78
3,035.81%
Selling and Distribution Expenses
5,490.12
390.09
5,100.03
1,307.40%
Other Expenses
13.61
3.47
10.14
292.22%
Total Expenditure (Excl Depreciation)
81,813.62
535.60
81,278.02
15,175.13%
Operating Profit (PBDIT) excl Other Income
3,113.77
81.40
3,032.37
3,725.27%
Other Income
262.37
2.00
260.37
13,018.50%
Operating Profit (PBDIT)
3,022.42
106.27
2,916.15
2,744.10%
Interest
392.29
12.51
379.78
3,035.81%
Exceptional Items
69.29
0.00
69.29
Gross Profit (PBDT)
9,132.24
518.65
8,613.59
1,660.77%
Depreciation
0.00
25.29
-25.29
-100.00%
Profit Before Tax
2,699.42
68.47
2,630.95
3,842.49%
Tax
642.18
7.14
635.04
8,894.12%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
1,599.84
57.69
1,542.15
2,673.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,599.84
57.69
1,542.15
2,673.17%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
487.87
3.90
483.97
12,409.49%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,087.71
61.59
2,026.12
3,289.69%
Equity Capital
0
0
0.00
Face Value
1.13
0.00
0.00
Reserves
87,729.91
1,662.55
86,067.36
5,176.83%
Earnings per share (EPS)
0.43
0.02
0.41
2,050.00%
Diluted Earnings per share
0.43
0.02
0.41
2,050.00%
Operating Profit Margin (Excl OI)
3.25%
12.80%
0.00
-9.55%
Gross Profit Margin
3.18%
15.20%
0.00
-12.02%
PAT Margin
1.88%
9.35%
0.00
-7.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 8,492.74 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 13.01% vs -6.41% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.25% vs -0.87% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 208.77 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 92.72% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 19.05% vs -13.60% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 276.00 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -0.79% vs 12.49% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -13.28% vs -3.05% in Mar 2025

Quarterly - Interest
Interest 39.23 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.74% vs 3.49% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -17.38% vs -7.48% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.25%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025